Showing results (941-950 of 3,659) with videos related to

Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|June 13, 2016
Contralateral prophylactic mastectomy (CPM): A systematic review of patient reported factors and psychological predictors influencing choice and satisfactionBrittany Ager, Phyllis Butow, Jesse Jansen, et al.
Breast (Edinburgh, Scotland)|March 28, 2016
Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancerMarta Scorsetti, Davide Franceschini, Fiorenza De Rose, et al.
Breast (Edinburgh, Scotland)|March 28, 2016
Male breast cancer: Looking for better prognostic subgroupsMiguel Henriques Abreu, Noémia Afonso, Pedro Henriques Abreu, et al.
Breast (Edinburgh, Scotland)|March 28, 2016
Does breast composition influence late adverse effects in breast radiotherapy?Prabhjot Juneja, Maria Bonora, Joanne S Haviland, et al.
Breast (Edinburgh, Scotland)|March 28, 2016
DIEAP flap for safe definitive autologous breast reconstructionKatrin Seidenstuecker, Carl van Waes, Beatrix I Munder, et al.
Breast (Edinburgh, Scotland)|March 28, 2016
The controversial role of human chorionic gonadotropin in the development of breast cancer and other types of tumorsCaroline Gehring, Timo Siepmann, Helene Heidegger, et al.
Breast (Edinburgh, Scotland)|March 31, 2016
Importance of patient reported outcome measures versus clinical outcomes for breast cancer patients evaluation on quality of careMelissa Kool, Joost R M van der Sijp, Judith R Kroep, et al.
Breast (Edinburgh, Scotland)|April 29, 2016
Surgical treatment of breast lesions at a Day Centre: Experience of the European Institute of OncologyBettina Ballardini, Marta Cavalli, Giovanni Francesco Manfredi, et al.
Breast (Edinburgh, Scotland)|November 28, 2015
Nipple sparing mastectomy: Surgical and oncological outcomes from a national multicentric registry with 913 patients (1006 cases) over a six year periodLorenzo Orzalesi, Donato Casella, Caterina Santi, et al.
Breast (Edinburgh, Scotland)|July 23, 2022
Cost-effectiveness of trastuzumab biosimilar combination therapy and drug wastage as first-line treatment for HER2-positive metastatic breast cancerJohn Hang Leung, Yun-Sheng Tai, Shyh-Yau Wang, et al.
Pageof 366